Publications by authors named "Anne Hertenstein"

10Publications

Neurological sequelae of cancer immunotherapies and targeted therapies.

Lancet Oncol 2016 Dec;17(12):e529-e541

Department of Neurology and Neurooncology Program, National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany; Brain Tumor Immunology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(16)30571-XDOI Listing
December 2016

Highlights in Central Nervous System Tumors.

JAMA Oncol 2016 Dec;2(12):1535-1536

Neurology Clinic and National Center for Tumor Disease, University of Heidelberg and German Cancer Research Center, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://oncology.jamanetwork.com/article.aspx?doi=10.1001/jam
Publisher Site
http://dx.doi.org/10.1001/jamaoncol.2016.3673DOI Listing
December 2016

Impact of tapering and discontinuation of bevacizumab in patients with progressive glioblastoma.

J Neurooncol 2016 09 15;129(3):533-539. Epub 2016 Jul 15.

Neurology Clinic & National Center for Tumor Disease, University of Heidelberg and German Cancer Research Center, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-016-2206-xDOI Listing
September 2016

Clinical parameters outweigh diffusion- and perfusion-derived MRI parameters in predicting survival in newly diagnosed glioblastoma.

Neuro Oncol 2016 12 13;18(12):1673-1679. Epub 2016 Jun 13.

Department of Neuroradiology, University of Heidelberg Medical Center, Heidelberg, Germany (S.B., P.K., O.E., D.B., L.W., M.B., A.R.); Division of Bioststatistics, German Cancer Research Center, Heidelberg, Germany (D.T.); Department of Neurology, University of Heidelberg Medical Center, Heidelberg, Germany (A.W., S.L., A.H., W.W.); Department of Neurology, Innsbruck Medical University, Innsbruck, Austria (M.N.); Department of Radiology, German Cancer Research Center, Heidelberg, Germany (H.S.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/now122DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5744248PMC
December 2016

Current status and future directions of anti-angiogenic therapy for gliomas.

Neuro Oncol 2016 Mar 12;18(3):315-28. Epub 2015 Oct 12.

Neurology Clinic and National Center for Tumor Diseases, University of Heidelberg and German Consortium for Translational Cancer Research, German Cancer Research Center, Heidelberg, Germany (W.W., M.P., A.W., A.H., F.W.); Department of Neuroradiology, University of Heidelberg and German Cancer Research Center, Heidelberg, Germany (A.R., M.B.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nov180DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4767238PMC
March 2016

Suppression of human CD4+ T cell activation by 3,4-dimethoxycinnamonyl-anthranilic acid (tranilast) is mediated by CXCL9 and CXCL10.

Biochem Pharmacol 2011 Sep 14;82(6):632-41. Epub 2011 Jun 14.

Department of Neurooncology, University Hospital Heidelberg, 69120 Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bcp.2011.06.013DOI Listing
September 2011